United States: President’s 2014 Budget Proposal For The Department Of Health And Human Services (HHS)

The Obama Administration released its proposed Fiscal Year 2014 budget on April 10th. The 244-page document outlines the President's spending priorities for the coming fiscal year. The FY 2014 Budget for the Department of Health and Human Services (HHS) totals $80.1 billion in discretionary funding for FY 2014, $3.9 billion above the 2012 enacted level.

Included in the President's Budget are significant payment reductions and other forms of savings to the Medicare program. Proposed payment changes for Medicare providers would save an estimated $306 billion from 2014-2023. Structural changes to Medicare, including an increase in premiums for wealthier beneficiaries, would provide $67 billion in savings over the same 10-year period. Also of note, the budget proposal includes over $800 million for the Centers for Medicare & Medicaid Services (CMS) to support insurance exchange operations in 2014 under the Affordable Care Act (ACA). The budget also includes $19 billion in Medicaid savings and over $14 billion in pharmaceutical savings by 2023. Overall, proposals achieve an estimated $400 billion in total health savings from 2014 through 2023.

This legislative update is intended to provide an overview of key elements of the proposed FY 2014 HHS budget.

Affordable Care Act Implementation

The FY 2014 Budget requests $634 million to employ an additional 280 full-time CMS employees to "oversee expanded responsibilities resulting from the Affordable Care Act (ACA) and other legislation passed in recent years." The additional employees would also support a new wave of Medicare beneficiaries and administer Medicaid and the Children's Health Insurance Program (CHIP). In addition the Budget requests $350 million in additional funding for approximately 1,000 new employees at the IRS to oversee implementation of the ACA.

The FY 2014 Budget also includes:

  • $803.5 million for CMS activities in 2014 to support ACA insurance exchange operations, scheduled to begin enrollment in October of 2013
  • $3.8 billion to support 22 million patients receiving community health center services. The ACA already provides the Health Center program with a total of $9.5 billion through 2015
  • A delay in reductions of the Medicaid Disproportionate Share Hospital (DSH) payments scheduled for 2014, which would instead begin in 2015.

Medicare and Medicaid

The FY 2014 Budget estimate for CMS is $854.3 billion in mandatory and discretionary outlays, an increase of $60.2 billion above the FY 2013 request. Specifically, the Budget includes $22.1 billion in savings over 10 years in the Medicaid program and savings of $371 billion over 10 years through changes to Medicare.

The biggest savings from Medicare, $50 billion, would come from additional means-testing Part B and Part D premiums for wealthier recipients beginning in 2017. The Budget would also modify Part B premiums for new enrollees, making beneficiaries pay 35 percent of program costs, up from 25 percent. It would introduce an approximate 15 percent surcharge for new beneficiaries in Medigap plans for beneficiaries beginning in 2017 to achieve $3.3 billion in savings by 2023. Notably, the proposal would not increase the eligibility age for Medicare.

The proposed Budget would also save $8.8 billion over 10 years, by implementing targeted adjustments in Medicaid prescription drug financing through clarifying the definition of brand drugs, excluding authorized generic drugs from average manufacturer price calculations for determining manufacturer rebate obligations for brand drugs, and making a technical correction to the ACA alternative rebate for new drug calculations.

Additional changes to Medicaid and Medicare include:

  • Stabilizing physician payment rates and eventually replacing the sustainable growth rate (SGR) through reforms implementing scalable accountable payment models
  • Instituting mandatory drug rebates in Medicare Part D for low-income seniors, which would save an estimated $140 billion
  • Closing the donut hole in the Part D benefit by 2015 for brand drugs by increasing discounts provided by the pharmaceutical industry
  • Requiring new beneficiaries, beginning in 2017, to pay copays on certain home health services and skilled nursing facilities (SNFs)
  • Aligning Medicare payments for drugs with Medicaid rebate policies for low-income beneficiaries
  • Using the Independent Payment Advisory Board (IPAB), created under the ACA, to reduce long-term drivers of Medicare cost growth
  • Reducing payment errors, preventing fraud, and enhancing criminal enforcement in Medicare, Medicaid, and CHIP.

National Institutes of Health

The FY 2014 Budget requests $31.3 billion for the National Institutes of Health (NIH), an increase of $471 million, 1.5 percent, over the FY 2012 funding level. The increase reflects the Administration's desire to prioritize investments in biomedical and behavioral science to advance medicine and spur economic growth. In FY 2014, 83 percent of funding appropriated to NIH will flow to the extramural community, supporting over 300,000 research positions at more than 2,500 organizations, while 11 percent of the budget will support intramural programs and basic research and training activities.

Research priorities for NIH in FY 2014 include:

  • $100 million to pursue the Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative, aimed at helping researchers explore new ways to treat, cure, and prevent brain disorders
  • $50 million to continue the work of the newly established National Center for Advancing Translational Sciences (NCATS), which seeks to re-engineer scientific discoveries into new diagnostics and therapeutics
  • $16.9 billion, or 54 percent of its total budget, to finance 36,510 competitive, peer-reviewed research project grants
  • The NIH budget also prioritizes funding for recruiting and retaining diverse scientific talent and creativity, HIV/AIDS research, and Science, Technology, Engineering, and Mathematics (STEM) education.

Food and Drug Administration

The FY 2014 Budget provides $4.7 billion in total program resources for the Food and Drug Administration (FDA), which is $821 million above the 2012 enacted level. It includes $10 million in new resources to improve the safety of food and medical product imports to the United States through a greater FDA presence in foreign countries. The proposal uses $16 million to implement the Food Safety Modernization Act while cutting $15 million in budget authority for human drug, biologics and medical device programs. The Budget also estimates that banning pay-for-delay settlements would save Medicare $8.6 billion over 10 years and reducing exclusivity for brand-name biologics to seven years from 12 years would save $3.1 billion in Medicare over 10 years.

Other Budget Highlights

In addition to the items highlighted above, the FY 2014 Budget proposal includes:

  • $11.3 billion for the Centers for Disease Control and Prevention (CDC) and the Agency for Toxic Substances and Disease Registry (ATSDR)
  • $5.7 billion for the Indian Health Service (IHS)
  • $3.6 billion for the Substance Abuse and Mental Health Service Administration (SAMSHA)
  • $9 billion for the Health Resources and Services Administration (HRSA), an increase of $841 million above FY 2012 levels
  • $434 million for the Agency for Healthcare Research and Quality (AHRQ)
  • $51.9 billion for the Administration for Children and Families (ACF)
  • $2.1 billion for the Administration for Community Living (ACL)
  • $25 million to the Office of the National Coordinator for Health IT (ONC) to support advances in electronic health records (EHRs).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Similar Articles
Relevancy Powered by MondaqAI
In association with
Related Topics
Similar Articles
Relevancy Powered by MondaqAI
Related Articles
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Registration (you must scroll down to set your data preferences)

Mondaq Ltd requires you to register and provide information that personally identifies you, including your content preferences, for three primary purposes (full details of Mondaq’s use of your personal data can be found in our Privacy and Cookies Notice):

  • To allow you to personalize the Mondaq websites you are visiting to show content ("Content") relevant to your interests.
  • To enable features such as password reminder, news alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our content providers ("Contributors") who contribute Content for free for your use.

Mondaq hopes that our registered users will support us in maintaining our free to view business model by consenting to our use of your personal data as described below.

Mondaq has a "free to view" business model. Our services are paid for by Contributors in exchange for Mondaq providing them with access to information about who accesses their content. Once personal data is transferred to our Contributors they become a data controller of this personal data. They use it to measure the response that their articles are receiving, as a form of market research. They may also use it to provide Mondaq users with information about their products and services.

Details of each Contributor to which your personal data will be transferred is clearly stated within the Content that you access. For full details of how this Contributor will use your personal data, you should review the Contributor’s own Privacy Notice.

Please indicate your preference below:

Yes, I am happy to support Mondaq in maintaining its free to view business model by agreeing to allow Mondaq to share my personal data with Contributors whose Content I access
No, I do not want Mondaq to share my personal data with Contributors

Also please let us know whether you are happy to receive communications promoting products and services offered by Mondaq:

Yes, I am happy to received promotional communications from Mondaq
No, please do not send me promotional communications from Mondaq
Terms & Conditions

Mondaq.com (the Website) is owned and managed by Mondaq Ltd (Mondaq). Mondaq grants you a non-exclusive, revocable licence to access the Website and associated services, such as the Mondaq News Alerts (Services), subject to and in consideration of your compliance with the following terms and conditions of use (Terms). Your use of the Website and/or Services constitutes your agreement to the Terms. Mondaq may terminate your use of the Website and Services if you are in breach of these Terms or if Mondaq decides to terminate the licence granted hereunder for any reason whatsoever.

Use of www.mondaq.com

To Use Mondaq.com you must be: eighteen (18) years old or over; legally capable of entering into binding contracts; and not in any way prohibited by the applicable law to enter into these Terms in the jurisdiction which you are currently located.

You may use the Website as an unregistered user, however, you are required to register as a user if you wish to read the full text of the Content or to receive the Services.

You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these Terms or with the prior written consent of Mondaq. You may not use electronic or other means to extract details or information from the Content. Nor shall you extract information about users or Contributors in order to offer them any services or products.

In your use of the Website and/or Services you shall: comply with all applicable laws, regulations, directives and legislations which apply to your Use of the Website and/or Services in whatever country you are physically located including without limitation any and all consumer law, export control laws and regulations; provide to us true, correct and accurate information and promptly inform us in the event that any information that you have provided to us changes or becomes inaccurate; notify Mondaq immediately of any circumstances where you have reason to believe that any Intellectual Property Rights or any other rights of any third party may have been infringed; co-operate with reasonable security or other checks or requests for information made by Mondaq from time to time; and at all times be fully liable for the breach of any of these Terms by a third party using your login details to access the Website and/or Services

however, you shall not: do anything likely to impair, interfere with or damage or cause harm or distress to any persons, or the network; do anything that will infringe any Intellectual Property Rights or other rights of Mondaq or any third party; or use the Website, Services and/or Content otherwise than in accordance with these Terms; use any trade marks or service marks of Mondaq or the Contributors, or do anything which may be seen to take unfair advantage of the reputation and goodwill of Mondaq or the Contributors, or the Website, Services and/or Content.

Mondaq reserves the right, in its sole discretion, to take any action that it deems necessary and appropriate in the event it considers that there is a breach or threatened breach of the Terms.

Mondaq’s Rights and Obligations

Unless otherwise expressly set out to the contrary, nothing in these Terms shall serve to transfer from Mondaq to you, any Intellectual Property Rights owned by and/or licensed to Mondaq and all rights, title and interest in and to such Intellectual Property Rights will remain exclusively with Mondaq and/or its licensors.

Mondaq shall use its reasonable endeavours to make the Website and Services available to you at all times, but we cannot guarantee an uninterrupted and fault free service.

Mondaq reserves the right to make changes to the services and/or the Website or part thereof, from time to time, and we may add, remove, modify and/or vary any elements of features and functionalities of the Website or the services.

Mondaq also reserves the right from time to time to monitor your Use of the Website and/or services.


The Content is general information only. It is not intended to constitute legal advice or seek to be the complete and comprehensive statement of the law, nor is it intended to address your specific requirements or provide advice on which reliance should be placed. Mondaq and/or its Contributors and other suppliers make no representations about the suitability of the information contained in the Content for any purpose. All Content provided "as is" without warranty of any kind. Mondaq and/or its Contributors and other suppliers hereby exclude and disclaim all representations, warranties or guarantees with regard to the Content, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. To the maximum extent permitted by law, Mondaq expressly excludes all representations, warranties, obligations, and liabilities arising out of or in connection with all Content. In no event shall Mondaq and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use of the Content or performance of Mondaq’s Services.


Mondaq may alter or amend these Terms by amending them on the Website. By continuing to Use the Services and/or the Website after such amendment, you will be deemed to have accepted any amendment to these Terms.

These Terms shall be governed by and construed in accordance with the laws of England and Wales and you irrevocably submit to the exclusive jurisdiction of the courts of England and Wales to settle any dispute which may arise out of or in connection with these Terms. If you live outside the United Kingdom, English law shall apply only to the extent that English law shall not deprive you of any legal protection accorded in accordance with the law of the place where you are habitually resident ("Local Law"). In the event English law deprives you of any legal protection which is accorded to you under Local Law, then these terms shall be governed by Local Law and any dispute or claim arising out of or in connection with these Terms shall be subject to the non-exclusive jurisdiction of the courts where you are habitually resident.

You may print and keep a copy of these Terms, which form the entire agreement between you and Mondaq and supersede any other communications or advertising in respect of the Service and/or the Website.

No delay in exercising or non-exercise by you and/or Mondaq of any of its rights under or in connection with these Terms shall operate as a waiver or release of each of your or Mondaq’s right. Rather, any such waiver or release must be specifically granted in writing signed by the party granting it.

If any part of these Terms is held unenforceable, that part shall be enforced to the maximum extent permissible so as to give effect to the intent of the parties, and the Terms shall continue in full force and effect.

Mondaq shall not incur any liability to you on account of any loss or damage resulting from any delay or failure to perform all or any part of these Terms if such delay or failure is caused, in whole or in part, by events, occurrences, or causes beyond the control of Mondaq. Such events, occurrences or causes will include, without limitation, acts of God, strikes, lockouts, server and network failure, riots, acts of war, earthquakes, fire and explosions.

By clicking Register you state you have read and agree to our Terms and Conditions